These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30781349)

  • 1. Defective Sphingolipids Metabolism and Tumor Associated Macrophages as the Possible Links Between Gaucher Disease and Blood Cancer Development.
    Wątek M; Piktel E; Wollny T; Durnaś B; Fiedoruk K; Lech-Marańda E; Bucki R
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gaucher disease and myeloma.
    Ayto R; Hughes DA
    Crit Rev Oncog; 2013; 18(3):247-68. PubMed ID: 23510067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary sphingolipid accumulation in a macrophage model of Gaucher disease.
    Hein LK; Meikle PJ; Hopwood JJ; Fuller M
    Mol Genet Metab; 2007 Dec; 92(4):336-45. PubMed ID: 17881272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of sphingolipids on osteoblast and osteoclast activity in Gaucher disease.
    Reed MC; Schiffer C; Heales S; Mehta AB; Hughes DA
    Mol Genet Metab; 2018 Aug; 124(4):278-286. PubMed ID: 29934064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher disease and multiple myeloma.
    Costello R; O'Callaghan T; Sébahoun G
    Leuk Lymphoma; 2006 Jul; 47(7):1365-8. PubMed ID: 16923570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease.
    Nascimbeni F; Dalla Salda A; Carubbi F
    Blood Cells Mol Dis; 2018 Feb; 68():74-80. PubMed ID: 27839982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gaucheromas: When macrophages promote tumor formation and dissemination.
    Ivanova M; Limgala RP; Changsila E; Kamath R; Ioanou C; Goker-Alpan O
    Blood Cells Mol Dis; 2018 Feb; 68():100-105. PubMed ID: 27839983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaucher Disease-Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant Myelopoiesis.
    Sgambato JA; Park TS; Miller D; Panicker LM; Sidransky E; Lun Y; Awad O; Bentzen SM; Zambidis ET; Feldman RA
    Stem Cells Transl Med; 2015 Aug; 4(8):878-86. PubMed ID: 26062980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phagocytosis of Erythrocytes from Gaucher Patients Induces Phenotypic Modifications in Macrophages, Driving Them toward Gaucher Cells.
    Dupuis L; Chauvet M; Bourdelier E; Dussiot M; Belmatoug N; Le Van Kim C; Chêne A; Franco M
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development.
    Panicker LM; Miller D; Awad O; Bose V; Lun Y; Park TS; Zambidis ET; Sgambato JA; Feldman RA
    Stem Cells; 2014 Sep; 32(9):2338-49. PubMed ID: 24801745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective reduction of bis(monoacylglycero)phosphate ameliorates the storage burden in a THP-1 macrophage model of Gaucher disease.
    Hein LK; Duplock S; Fuller M
    J Lipid Res; 2013 Jun; 54(6):1691-1697. PubMed ID: 23564732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease.
    Panicker LM; Miller D; Park TS; Patel B; Azevedo JL; Awad O; Masood MA; Veenstra TD; Goldin E; Stubblefield BK; Tayebi N; Polumuri SK; Vogel SN; Sidransky E; Zambidis ET; Feldman RA
    Proc Natl Acad Sci U S A; 2012 Oct; 109(44):18054-9. PubMed ID: 23071332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis.
    Lo SM; Choi M; Liu J; Jain D; Boot RG; Kallemeijn WW; Aerts JM; Pashankar F; Kupfer GM; Mane S; Lifton RP; Mistry PK
    Blood; 2012 May; 119(20):4731-40. PubMed ID: 22493294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlating liver stiffness with disease severity scoring system (DS3) values in Gaucher disease type 1 (GD1) patients.
    Serai SD; Naidu AP; Andrew Burrow T; Prada CE; Xanthakos S; Towbin AJ
    Mol Genet Metab; 2018 Mar; 123(3):357-363. PubMed ID: 29361370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iPSC-Derived Gaucher Macrophages Display Growth Impairment and Activation of Inflammation-Related Cell Death.
    Messelodi D; Bertuccio SN; Indio V; Strocchi S; Taddia A; Serravalle S; Bandini J; Astolfi A; Pession A
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism.
    Mistry PK; Taddei T; vom Dahl S; Rosenbloom BE
    Crit Rev Oncog; 2013; 18(3):235-46. PubMed ID: 23510066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.
    Stirnemann J; Belmatoug N; Camou F; Serratrice C; Froissart R; Caillaud C; Levade T; Astudillo L; Serratrice J; Brassier A; Rose C; Billette de Villemeur T; Berger MG
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry.
    Nguyen Y; Stirnemann J; Lautredoux F; Cador B; Bengherbia M; Yousfi K; Hamroun D; Astudillo L; Billette de Villemeur T; Brassier A; Camou F; Dalbies F; Dobbelaere D; Gaches F; Leguy-Seguin V; Masseau A; Pers YM; Pichard S; Serratrice C; Berger MG; Fantin B; Belmatoug N; On Behalf Of The French Evaluation Of Gaucher Disease Treatment Committee
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32069933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Pathophysiologic Cascade Leading to Osteoclastogenic Activation in Gaucher Disease Monocytes Generated via CRISPR/Cas9 Technology.
    Ormazabal ME; Pavan E; Vaena E; Ferino D; Biasizzo J; Mucci JM; Serra F; Cifù A; Scarpa M; Rozenfeld PA; Dardis AE
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal properties of red blood cells suggest a role in the pathophysiology of Gaucher disease.
    Franco M; Collec E; Connes P; van den Akker E; Billette de Villemeur T; Belmatoug N; von Lindern M; Ameziane N; Hermine O; Colin Y; Le Van Kim C; Mignot C
    Blood; 2013 Jan; 121(3):546-55. PubMed ID: 23212518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.